Steve Aselage is a director of Acer Therapeutics Inc.
Person profile
Roles
Address
Fremont, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Acer Therapeutics Inc.
16 Mar 23
4
Acer Therapeutics Inc.
1 Dec 22
4
BIOCRYST PHARMACEUTICALS INC
9 Jun 22
4
BIOCRYST PHARMACEUTICALS INC
2 Jun 22
4
Travere Therapeutics, Inc.
12 May 22
4
BIOCRYST PHARMACEUTICALS INC
2 Mar 22
4
Acer Therapeutics Inc.
19 Jan 22
4
Acer Therapeutics Inc.
13 Dec 21
4
BIOCRYST PHARMACEUTICALS INC
2 Dec 21
4
Travere Therapeutics, Inc.
18 Nov 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Mar 23 | ACER Acer Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 20,000 | 33.40 k | 20,000 |
| 29 Nov 22 | ACER Acer Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.22 | 409,836 | 500.00 k | 483,741 |
| 7 Jun 22 | BCRX Biocryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 12,866 | 0.00 | 46,594 |
| 7 Jun 22 | BCRX Biocryst Pharmaceuticals | Automatic Stock Option Grant Common Stock | Grant | Acquire A | No | No | 10.79 | 30,022 | 323.94 k | 30,022 |
| 31 May 22 | BCRX Biocryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 9.31 | 569 | 5.30 k | 33,728 |
| 11 May 22 | TVTX Travere Therapeutics | Common Stock | Sell | Dispose S | No | No | 21.9249 | 2,575 | 56.46 k | 146,919 |